Persistent bilateral ureteral obstruction secondary to endometriosis despite treatment with an aromatase inhibitor.
OBJECTIVE
To present a case demonstrating lack of efficacy of an aromatase inhibitor in treating ureteral endometriosis.


METHODS
Case report.


METHODS
A tertiary-care hospital.


METHODS
A 47-year-old woman with severe ureteral endometriosis.


METHODS
Anastrozole 1 mg daily for 15 months.


METHODS
Renal function.


RESULTS
Despite medical management with anastrozole, our patient continued to have worsening renal function and subsequently required surgical intervention.


CONCLUSIONS
Anastrozole was ineffective at preventing deterioration of renal function in this patient.
Bohrer
Justin
J
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA.
Chen
Chi Chiung Grace
CC
Falcone
Tommaso
T
D000077384:Anastrozole; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D018450:Disease Progression; D004715:Endometriosis / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery; D005260:Female; D006801:Humans; D007677:Kidney Function Tests; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use*; D012720:Severity of Illness Index; D015607:Stents; D017211:Treatment Failure; D014230:Triazoles / Q000627:therapeutic use*; D014515:Ureteral Diseases / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery; D014517:Ureteral Obstruction / Q000209:etiology* / Q000503:physiopathology / Q000601:surgery; D013520:Urologic Surgical Procedures / Q000295:instrumentation
D047072:Aromatase Inhibitors; D009570:Nitriles; D014230:Triazoles; D000077384:Anastrozole